Trastuzumab-DM1 is highly effective in preclinical models of HER2-positive gastric cancer. (Q45928785)
Jump to navigation
Jump to search
scientific article published in April 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Trastuzumab-DM1 is highly effective in preclinical models of HER2-positive gastric cancer. |
scientific article published in April 2011 |
Statements
1 reference
Trastuzumab-DM1 is highly effective in preclinical models of HER2-positive gastric cancer. (English)
1 reference
Mark Barok
1 reference
Minna Tanner
1 reference
Katri Köninki
1 reference
Jorma Isola
1 reference
1 April 2011
1 reference
1 reference
306
1 reference
2
1 reference
171-179
1 reference
Identifiers
1 reference
1 reference